Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Profound Medical (PROF) Gross Margin (2019 - 2026)

Profound Medical has reported Gross Margin over the past 7 years, most recently at 66.77% for Q4 2025.

  • For Q4 2025, Gross Margin fell 416.0% year-over-year to 66.77%; the TTM value through Dec 2025 reached 70.77%, up 304.0%, while the annual FY2025 figure was 70.77%, 488.0% up from the prior year.
  • Gross Margin for Q4 2025 was 66.77% at Profound Medical, down from 74.32% in the prior quarter.
  • Over five years, Gross Margin peaked at 139.49% in Q4 2023 and troughed at 16.35% in Q4 2022.
  • A 5-year average of 58.37% and a median of 62.49% in 2024 define the central range for Gross Margin.
  • Biggest five-year swings in Gross Margin: crashed -10807bps in 2021 and later skyrocketed 15584bps in 2023.
  • Year by year, Gross Margin stood at 49.8% in 2021, then plummeted by -133bps to 16.35% in 2022, then skyrocketed by 953bps to 139.49% in 2023, then tumbled by -49bps to 70.93% in 2024, then fell by -6bps to 66.77% in 2025.
  • Business Quant data shows Gross Margin for PROF at 66.77% in Q4 2025, 74.32% in Q3 2025, and 73.18% in Q2 2025.